INZY•benzinga•
Needham Downgrades Inozyme Pharma to Hold, Maintains Price Target to $12
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2025 by benzinga